CoChat

Beyond Efficacy: The STAR*D Trial

Insel, Thomas R. · 2006 · American Journal of Psychiatry
Cited by 104

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Psychiatrists have a range of treatments to offer patients with depression.Randomized controlled trials have demonstrated the efficacy of tricyclic antidepressants, SSRIs, cognitive behavior therapy, and interpersonal therapy.For each of these interventions, one can say with some confidence that at least 40% of a cohort with depression will show statistically significant reductions in unbiased ratings of depression.This information, while entirely commendable in the world of research, is far from satisfactory in the world of practice where an individual clinician needs to make treatment decisions to help an individual patient.The practical questions that the clinician might ask include: For this specific patient, what is the best of the available treatments?What magnitude of response can my patient realistically expect in 4 or 6 weeks?And what should I do if my patient is not sufficiently better in this period: continue or switch treatments?If the first treatment does not work, what is the next best option?So what does this approach tell us?This first report of the STAR*D trial includes only Phase 1 results (N=2,876) but already provides important, practical answers.First, only about 30% of patients met criteria for remission during citalopram treatment.For remission, the mean dose of citalopram (41.8 mg/day) was higher and the mean duration of treatment (47 days with 5.5 visits) was longer than might have been expected on the basis of current clinical practice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.163.1.5

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 104

Metadata

Authors
Insel, T. R.
Venue
American Journal of Psychiatry
Published
2006-01-01
Volume
163
Issue
1
Pages
5-7
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2136887049
Cited by
104
References
2
FWCI
5.85
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Beyond Efficacy: The STAR*D Trial. https://app.cochat.ai/papers/10.1176/appi.ajp.163.1.5
The paper
Insel, T. R. (2006). Beyond Efficacy: The STAR*D Trial. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.163.1.5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.